167 related articles for article (PubMed ID: 1909351)
1. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.
Dent JA; Galbusera M; Ruggeri ZM
J Clin Invest; 1991 Sep; 88(3):774-82. PubMed ID: 1909351
[TBL] [Abstract][Full Text] [Related]
2. Subunit composition of plasma von Willebrand factor multimers: evidence for a non-proteolytic mechanism resulting in apparent increase in proteolytic fragments.
Tsai HM; Nagel RL; Sussman II
Thromb Res; 1991 Jul; 63(1):179-88. PubMed ID: 1948818
[TBL] [Abstract][Full Text] [Related]
3. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
[TBL] [Abstract][Full Text] [Related]
4. Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE).
Zimmerman TS; Dent JA; Ruggeri ZM; Nannini LH
J Clin Invest; 1986 Mar; 77(3):947-51. PubMed ID: 3485111
[TBL] [Abstract][Full Text] [Related]
5. Triplet structure of human von Willebrand factor.
Fischer BE; Thomas KB; Schlokat U; Dorner F
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):483-8. PubMed ID: 9531488
[TBL] [Abstract][Full Text] [Related]
6. Human von Willebrand factor: a multivalent protein composed of identical subunits.
Chopek MW; Girma JP; Fujikawa K; Davie EW; Titani K
Biochemistry; 1986 Jun; 25(11):3146-55. PubMed ID: 3015199
[TBL] [Abstract][Full Text] [Related]
7. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma.
Tsai HM; Sussman II; Nagel RL
Blood; 1994 Apr; 83(8):2171-9. PubMed ID: 8161783
[TBL] [Abstract][Full Text] [Related]
8. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
Ruggeri ZM; Zimmerman TS
J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
[TBL] [Abstract][Full Text] [Related]
9. Evidence that calpains and elastase do not produce the von Willebrand factor fragments present in normal plasma and IIA von Willebrand disease.
Berkowitz SD; Nozaki H; Titani K; Murachi T; Plow EF; Zimmerman TS
Blood; 1988 Aug; 72(2):721-7. PubMed ID: 2840990
[TBL] [Abstract][Full Text] [Related]
10. Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.
Hamilton KK; Fretto LJ; Grierson DS; McKee PA
J Clin Invest; 1985 Jul; 76(1):261-70. PubMed ID: 3160727
[TBL] [Abstract][Full Text] [Related]
11. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.
Tsai HM
Blood; 1996 May; 87(10):4235-44. PubMed ID: 8639782
[TBL] [Abstract][Full Text] [Related]
12. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
13. Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex.
Aihara M; Sawada Y; Ueno K; Morimoto S; Yoshida Y; de Serres M; Cooper HA; Wagner RH
Thromb Haemost; 1986 Apr; 55(2):263-7. PubMed ID: 3087003
[TBL] [Abstract][Full Text] [Related]
14. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of von Willebrand factor binding to platelet glycoprotein Ib and collagen. Effects of disulfide reduction and limited proteolysis of polymeric von Willebrand factor.
Bockenstedt P; Greenberg JM; Handin RI
J Clin Invest; 1986 Mar; 77(3):743-9. PubMed ID: 2936763
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin.
Berkowitz SD; Dent J; Roberts J; Fujimura Y; Plow EF; Titani K; Ruggeri ZM; Zimmerman TS
J Clin Invest; 1987 Feb; 79(2):524-31. PubMed ID: 2433308
[TBL] [Abstract][Full Text] [Related]
17. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.
Furlan M; Robles R; Lämmle B
Blood; 1996 May; 87(10):4223-34. PubMed ID: 8639781
[TBL] [Abstract][Full Text] [Related]
18. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Oct; 12(4):397-420. PubMed ID: 17000885
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
20. Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease.
Levene RB; Booyse FM; Chediak J; Zimmerman TS; Livingston DM; Lynch DC
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6550-4. PubMed ID: 3306682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
